Merck (MRK) Interest & Investment Income (2011 - 2013)

Merck (MRK) posted quarterly Interest & Investment Income of $57.0 million for Q1 2013, up 3.64% YoY from $55.0 million in Q1 2012, and up 3.64% sequentially from $55.0 million in Q4 2012.

Merck (MRK) Interest & Investment Income (2011 - 2013) Analysis & Trends

Merck has disclosed Interest & Investment Income across 3 years of filings, most recently posting $57.0 million for Q1 2013.

  • In Q1 2013, Interest & Investment Income rose 3.64% year-over-year to $57.0 million; the TTM figure through Mar 2013 stood at $214.0 million (changed N/A YoY), while the FY2012 annual figure was $1.8 billion, changed 0.0% from the prior year.
  • Interest & Investment Income grew to $57.0 million in Q1 2013, from $55.0 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for MRK reached as high as $57.0 million in Q1 2013 and fell as low as $32.0 million in Q3 2011.
  • The 3-year median for Interest & Investment Income is $51.0 million (2012), against an average of $48.2 million.
  • Annual changes were most pronounced in 2012 — Interest & Investment Income jumped 46.88% — and 2013, when it gained 3.64%.
  • A 3-year view of Interest & Investment Income shows it stood at $43.0 million in 2011, then gained by 27.91% to $55.0 million in 2012, then grew by 3.64% to $57.0 million in 2013.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $57.0 million, $55.0 million, and $47.0 million for Q1 2013, Q4 2012, and Q3 2012 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 229.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -645.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 73.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2013 57.00 Mn
Dec 31, 2012 55.00 Mn
Sep 30, 2012 47.00 Mn
Mar 31, 2012 55.00 Mn
Dec 31, 2011 43.00 Mn
Sep 30, 2011 32.00 Mn